Cellectar Biosciences Cash Flow Statement (2009-2014) | CLRB

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014
Operating Activities
Net Income -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M-0.37M-1.01M-2.52M-1.91M-31.71M-2.33M-2.21M-2.06M-40.48M-2.71M-2.72M-2.91M-52.89M-2.89M
Share-based Compensation 0.13M0.23M0.14M0.36M-0.10M0.34M0.09M0.02M0.06M0.20M0.40M2.85M0.42M0.41M0.34M4.36M0.43M0.38M0.30M6.68M0.26M0.27M0.15M
Gains from Investment Securities -0.03M-0.04M-0.04M-0.04M-0.04M-0.04M-0.00M-0.04M-0.04M-0.04M0.02M0.03M0.38M
Asset Writedowns and Impairment 0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Non-cash Items 5.04M0.12M
Cash from Operations -3.49M-2.46M-2.38M-2.29M-3.32M0.67M-0.62M-0.11M-0.32M-22.07M-23.60M-25.13M-1.70M-28.33M-30.02M-31.72M-1.89M-35.64M-38.19M-40.87M-2.59M-2.01M-2.10M
Depreciation, Depletion & Amortization
Amortization 21.67M21.67M20.38M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M0.03M0.26M0.14M0.14M0.14M2.12M2.27M2.42M0.14M2.68M2.80M2.91M0.11M3.13M3.24M3.34M0.10M0.09M0.09M
Change in Working Capital
Change in Accured Expenses -0.56M0.10M0.29M0.46M0.46M0.46M-0.01M0.46M0.46M0.46M0.15M0.64M0.78M0.78M-0.17M0.20M-0.06M
Investing Activities
Capital Expenditures 5.39M5.48M5.49M0.02M5.52M5.52M5.58M0.09M5.68M5.72M5.73M0.02M0.00M
Sales of Property, Plant and Equipment 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Intangibles 0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Acquisitions 0.91M0.91M0.91M0.91M0.91M0.91M
Change in Acquisitions & Divestments 5.50M5.50M5.50M5.50M5.50M5.50M5.50M5.50M5.50M
Cash from Investing Activities -4.55M-4.64M-4.65M-0.02M-4.68M-4.69M-6.75M0.03M-6.72M-4.88M-4.89M-0.02M-0.00M
Financing Activities
Other financing activities 35.70M35.13M41.01M49.18M56.49M56.05M56.36M75.29M-0.03M-0.13M0.16M0.03M0.03M-0.04M0.07M0.03M0.03M0.03M-0.17M0.69M
Debt Issuance and Repayment
Long-Term Debt Issuances 2.72M2.72M2.72M2.72M2.72M2.72M2.72M2.72M2.72M4.00M
Long-Term Debt Repayments 0.05M0.05M0.05M1.23M1.23M1.23M544.001.23M1.23M1.23M584.001.23M1.23M1.23M626.00637.000.62M
Change in Capital Stock
Shares Issued 5.49M0.16M0.00M26.58M26.58M31.87M36.75M0.15M38.71M4.98M43.69M43.69M43.69M12.40M
Shares Repurchased 0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Preferred Shares Issued 9.20M
Misc.
Cash from Financing Activities 9.20M3.45M5.49M0.16M2.56M-0.04M0.40M-0.05M29.93M29.83M35.29M-544.0040.16M40.31M43.14M5.05M48.19M48.19M48.18M4.00M-0.17M12.05M
Change in Cash 5.71M-2.48M1.07M3.20M-3.16M3.23M-0.66M0.29M-0.38M3.31M1.59M5.51M-1.72M7.15M5.60M4.68M3.18M5.83M5.11M2.42M1.39M-2.18M9.95M
Beginning Cash Balance 1.26M
Free Cash Flow -3.49M-2.46M-2.38M-2.29M-3.32M0.67M-0.62M-0.11M-0.32M-27.46M-29.08M-30.62M-1.72M-33.85M-35.55M-37.30M-1.98M-41.32M-43.91M-46.60M-2.61M-2.01M-2.10M
Net Cash Flow 5.71M-2.46M1.07M3.20M-3.16M3.23M-0.66M0.29M-0.38M3.31M1.59M5.51M-1.72M7.15M5.60M4.68M3.18M5.83M5.11M2.42M1.39M-2.18M9.95M